Thermo Fisher Scientific Inc., a world leader in serving science, today announced it has entered into an agreement to acquire Biolab, the leading provider of analytical instruments, life science consumables and laboratory equipment for scientific, environmental and healthcare markets in Australia and New Zealand, for AUD $175 million.
BioTek Instruments announced today the incorporation and expansion of BioTek Instruments Singapore, Pte. Ltd. This new and independent company will provide even greater support for the Asia Pacific distribution network and end-user customers.
BioFocus DPI, a leading provider of gene-to-candidate discovery services, and TET Systems Holding, a privately-held, German-based biotech company, announced today that they have entered into an agreement to apply TET System's inducible gene technology in high-throughput screening campaigns performed for BioFocus DPI customers.
At the 100th annual meeting of the American Association of Cancer Research being held at the Colorado Convention Center in Denver, Aperio Technologies, a global leader in digital pathology for the healthcare and life sciences industry, unveiled its new digital slide scanner dedicated to fluorescence whole slide scanning.
Asylum Research, in conjunction with IMETUM, Nano Initiative Munich, and Atomic Force F+E, announces the 2nd Euro AFM Forum to be held at the Technical University of Munich, Garching, Germany, July 1-3, 2009.
Nanosys Inc. today announced that it has signed two agreements with Harvard University to combine their extensive intellectual property (IP) assets to facilitate out-licensing in two areas: nanowire-based biosensors and nanowire-based non-volatile memories.
ApNano Materials, Inc., a cleantech company and provider of nanotechnology-based products, today announced that new test conducted at the FZG Gear Research Centre of the Technical University of Munich, Germany, clearly shows that ApNano Material?s nanotechnology-based lubricant NanoLub significantly decreases damaging wear pits on gear teeth.
nanoTox Inc. announced today that its Chief Scientific Officer, Dr. David W. Hobson, will share his insight on impending regulations and policies surrounding nanotech product safety during the NSTI Nanotech conference and exposition in Houston, Texas.
Genetic Immunity has announced that Julianna Lisziewicz, Chief Executive Officer of the Company will be presenting at the European Conference for Clinical Nanomedicine, to be held from April 26-29, 2009 at the Basel Convention Center in Basel, Switzerland.
NanoBio Corp. announced today that it will present compelling new data highlighting key milestones in the development of its novel non-inflammatory nanoemulsion adjuvant platform technology at the National Foundation for Infectious Diseases (NFID) conference, April 27-29.
BASF Fuel Cell GmbH presents new products for fuel cells and reformers on Hanover Fair 2009. A team of experts is available for visitors in hall 13, booth E 54/2, and informs about the latest developments.